Pancreatic Cancer
Conditions
Brief summary
After informed consent, participants will be asked to complete a medical/family history questionnaire and provide a blood sample. Some participants may also be asked to provide a urine sample. Individuals undergoing procedures that require collection of biological samples for clinical purposes may have these samples saved for research purposes. Participants will also be asked for their permission for study investigators to access medical records and/or recontact them for updates to their medical and family histories. Data and biospecimens will be stored for potential future research projects.
Interventions
None listed
Sponsors
University of Pittsburgh
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Histologically confirmed or CT confirmed diagnosis of pancreatic adenocarcinoma * Subjects with abnormal imaging study (CT, MRI, MRCP, EUS) * Control subjects with a clinical diagnosis of a pancreas, liver, or intestinal condition * Control subject with acute pancreatitis * Control subject with chronic pancreatitis * Control subject with biliary obstruction * Control subject with pancreatic cyst * Member of a high risk family (≥ 1 close relative with pancreatic cancer) * Healthy control (without any of the above conditions)
Exclusion criteria
* Under the age of 18 years * Unable to give informed consent * Inability to travel to Pittsburgh for in-person enrollment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The data will be used in cohort association studies. Endpoints will depend on the number of patients in the study and the number of markers that are being evaluated. | 10 years |
Countries
United States
Contacts
Primary ContactRandall E Brand, MD
Backup ContactBeth Dudley, MS, MPH, CGC
Outcome results
None listed